ProBioGen AG
Anneliese Krueger is an experienced professional in the biotechnology field, currently serving as Project Leader for Pharmaceutical Cell Line Development at ProBioGen AG since March 2019, with prior roles as Research Scientist and Associate Scientist. In November 2018, Anneliese held the position of Product Manager at SteriPharm Export GmbH, focusing on regulatory affairs and scientific support for the registration of dietary supplements abroad. Anneliese's academic background includes a Master of Science in Biotechnology from Berlin University of Applied Sciences and practical experience as a Master-Student at Fraunhofer IZI-BB, a Werkstudentin at Beuth Hochschule für Technik Berlin, and another Werkstudentin role at FMP Berlin, gaining expertise in various research areas including cell-free synthesis and blood-brain barrier modulation.
ProBioGen AG
ProBioGen AG is a renowned Contract Development and Manufacturing Organization (CDMO) and technology provider. We perform cell line engineering, process development, and GMP manufacturing of biopharmaceuticals for clients in biotech and pharma. We offer proprietary innovative technologies for optimized biopharmaceutical manufacturing and analysis. ProBioGen also provides process development services and manufacturing technologies for viral vaccines. Our additional new building houses 1000 L single-use bioreactor capacity to keep up with the ever-increasing demand from our clients. A second 1000 L single-use bioreactor is coming soon. With over 25 years of experience in animal cell culture, combined with innovative scientific excellence and a strong intellectual property base, we cover the entire drug development value chain end-to-end.